Indegene Limited (NSE:INDGN)

India flag India · Delayed Price · Currency is INR
477.15
+2.45 (0.52%)
Feb 16, 2026, 3:29 PM IST
Market Cap113.93B -22.1%
Revenue (ttm)32.63B +18.4%
Net Income4.39B +14.4%
EPS18.21 +11.5%
Shares Out240.01M
PE Ratio26.06
Forward PE22.96
Dividend2.00 (0.42%)
Ex-Dividend Daten/a
Volume771,628
Average Volume337,082
Open483.00
Previous Close474.70
Day's Range471.30 - 486.55
52-Week Range455.60 - 632.90
Betan/a
RSI41.23
Earnings DateJan 29, 2026

About Indegene

Indegene Limited operates as a digital-first life sciences commercialization company in India, the United States, Europe, and internationally. It operates through three segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation & Others. The company develops biotech and medical device for biopharmaceutical, emerging biotech, and medical device companies. It also offers enterprise commercial, medical, and clinical solutions; and omnichannel activation solutions. In addition, the company operates NEXT technolo... [Read more]

Sector Healthcare
Founded 1998
Employees 4,158
Stock Exchange National Stock Exchange of India
Ticker Symbol INDGN
Full Company Profile

Financial Performance

In fiscal year 2025, Indegene's revenue was 28.39 billion, an increase of 9.64% compared to the previous year's 25.90 billion. Earnings were 4.07 billion, an increase of 20.79%.

Financial Statements